JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M109452200 on February 1, 2002

J. Biol. Chem., Vol. 277, Issue 16, 14206-14210, April 19, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/16/14206    most recent
M109452200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zingman, L. V.
Right arrow Articles by Terzic, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zingman, L. V.
Right arrow Articles by Terzic, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Tandem Function of Nucleotide Binding Domains Confers Competence to Sulfonylurea Receptor in Gating ATP-sensitive K+ Channels*

Leonid V. ZingmanDagger , Denice M. HodgsonDagger , Martin BienengraeberDagger , Amy B. KargerDagger , Eva C. KathmannDagger , Alexey E. AlekseevDagger §, and Andre TerzicDagger

From the Dagger  Division of Cardiovascular Diseases, Departments of Medicine, Molecular Pharmacology, and Experimental Therapeutics, Mayo Clinic, Mayo Foundation, Rochester, Minnesota 55905 and the § Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, 142290 Puschino, Russia

Received for publication, October 1, 2001, and in revised form, January 30, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Fundamental to the metabolic sensor function of ATP-sensitive K+ (KATP) channels is the sulfonylurea receptor. This ATP-binding cassette protein, which contains nucleotide binding domains (NBD1 and NBD2) with conserved Walker motifs, regulates the ATP sensitivity of the pore-forming Kir6.2 subunit. Although NBD2 hydrolyzes ATP, a property essential in KATP channel gating, the role of NBD1, which has limited catalytic activity, if at all, remains less understood. Here, we provide functional evidence that cooperative interaction, rather than the independent contribution of each NBD, is critical for KATP channel regulation. Gating of cardiac KATP channels by distinct conformations in the NBD2 ATPase cycle, induced by gamma -phosphate analogs, was disrupted by point mutation not only of the Walker motif in NBD2 but also in NBD1. Cooling membrane patches to decelerate the intrinsic ATPase activity counteracted ATP-induced KATP channel inhibition, an effect that mimicked stabilization of the MgADP-bound posthydrolytic state at NBD2 by the gamma -phosphate analog orthovanadate. Temperature-induced channel activation was abolished by mutations that either prevent stabilization of MgADP at NBD2 or ATP at NBD1. These findings provide a paradigm of KATP channel gating based on integration of both NBDs into a functional unit within the multimeric channel complex.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Bifunctional protein complexes that combine catalytic and conduction properties have been discovered recently (1-5). A prototypic channel/enzyme multimer is the ATP-sensitive potassium (KATP)1 channel complex. Indeed, K+ permeation through the channel pore is inhibited by direct binding of ATP to the Kir6.2 pore-forming subunit and can be gated through an ATPase cycle within the sulfonylurea receptor (SUR) subunit (3, 5-9). The central role for SUR in defining the ATP sensitivity of KATP channels is underscored by the abnormal cellular responses, associated with life-threatening disease, that result from malfunction of this regulatory channel module (7-10). In fact, the ATPase function of the SUR subunit has been proposed to translate intracellular metabolic signals into membrane electrical events (5, 11). However, the components of SUR responsible for signal transduction within the KATP channel complex remain to be established.

As a member of the ATP-binding cassette (ABC) protein family, SUR contains two consensus sequences for nucleotide binding and hydrolysis known as nucleotide binding domains or NBDs (12-14). Both NBDs are apparently required for optimal performance in ABC proteins (15, 16). A deficit in one disrupts the function of the other domain and the ABC protein as a whole, suggesting an interdependence of NBD functions (17-19). In SUR, mutations in the conserved NBD1 Walker A motif prevent ATP binding at both NBDs (20)2 and interfere with the stimulatory effect of KATP channel regulators, which act through NBD2 (21-25). Conversely, MgADP at NBD2 promotes stabilization of ATP at NBD1 indicating cooperative nucleotide binding at the NBDs of KATP channels (6, 19, 26). NBD2 of SUR has been assigned the role of ATP hydrolysis (3, 6, 19), and discrete conformations driven by this intrinsic ATPase cycle have been identified as essential in channel gating (5). In contrast, NBD1 has limited catalytic activity (3), if at all (6, 19), and the role of this domain in KATP channel gating remains less understood (21, 27, 28).

Here, we report that an intact NBD1 is mandatory for NBD2 ATPase-dependent KATP channel gating. Stabilization of ATP at NBD1 depends on, and simultaneously promotes, engagement of NBD2 into a MgADP-bound conformation required to counteract ATP-induced pore closure. Thus, rather than individual components of the regulatory subunit, it is the functional tandem formed by NBD1 and NBD2 that drives SUR-mediated nucleotide-dependent gating of the KATP channel complex.

    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

ATPase Activity in NBD2-- The ATPase activity in the second nucleotide binding domain (NBD2) of the cardiac sulfonylurea receptor (SUR2A) was measured as described (3, 5). In brief, recombinant NBD2 (Gly1306-Thr1498) was purified from Escherichia coli as a fusion to maltose binding protein using affinity chromatography on an amylose resin in (mM) 600 NaCl, 1 EDTA, 20 Tris (pH 7.4), and 10% glycerol. Products of [gamma -32P]ATP hydrolysis, measured in (mM) 34 KCl, 8 MgCl2, 50 HEPES (pH 7.4), 4 ATP, and 10% glycerol (1 h, 37 °C), were then resolved by polyethyleneimine thin layer chromatography (Cellulose PEI TLC, Sigma) in 0.75 M KH2PO4 (pH 4.8). ATPase activity of NBD2 (10 µg) was quantified with a PhosphorImager and ImageQuant software (Molecular Dynamics).

Site-directed Mutagenesis-- Point mutations in the core consensus sequence of the Walker motifs of NBD1 and NBD2 in the hamster cardiac SUR isoform, SUR2A, were introduced in the pCDNA3.1 plasmid by PCR amplification of both DNA strands with complementary primers containing desired amino acid changes (QuickChange, Stratagene). Primers were designed to contain 30 bases harboring the mutation in the middle, with at least one base at the 3' end being C or G. Mutated constructs were sequenced to confirm point mutations and rule out additional changes in the sequence (3).

Transfection of Kir6.2 and SUR2A Clones-- COS-1 cells were cultured in Dulbecco's modified Eagle's medium with 10% fetal calf serum plus 2 mM glutamine and seeded at 2 × 106 cells prior to transfection. Kir6.2, with wild-type or mutated SUR2A, were subcloned into the expression vector pCDNA3.1 (5, 14). COS cells were transiently transfected with plasmids using LipofectAMINE 2000 (Invitrogen). pCDNA3.1-SUR2A (10 µg) and pCDNA3.1-Kir6.2 (1 µg) were included with the expression vector for green fluorescent protein (0.5 µg of pGREEN-lantern, Invitrogen) used as a reporter gene.

Electrophysiological Measurements-- Channel behavior was recorded in isolated ventricular myocytes dissociated from guinea pig hearts (29) as well as in COS-1 cells expressing recombinant KATP channels (5). Pipettes (~7-10 MOmega ) were filled with (in mM) KCl 140, CaCl2 1, MgCl2 1, HEPES-KOH 5 (pH 7.3). For the inside-out configuration, cells were superfused with "internal solution" (in mM) KCl 140, MgCl2 1, EGTA 5, HEPES-KOH 5 (pH 7.3). For the open cell-attached patch, internal solution was supplemented with glucose (1 g/liter), malic acid (5 mM), and pyruvic acid (5 mM). Following seal formation, the open cell-attached configuration was obtained by applying digitonin (8 µg/ml) through a second pipette (filled with 5 µg/ml propidium iodide and 0.5 µg/ml rhodamine). Solution flow was visualized by rhodamine under ultraviolet light, and staining of the cell nucleus with propidium iodide served as a criterion for plasmalemmal permeabilization. Data were expressed as means ± S.E.

Nucleotide Occlusion Procedures-- In conjunction with current recording, two established approaches (30-34) were employed to trap nucleotides within the catalytic site of the KATP channel ATPase. First, gamma -phosphate analogs, orthovanadate and beryllium fluoride, were used to stabilize MgADP in the post- and prehydrolytic states of SUR, respectively (5, 32-34). To this end, sodium vanadate (100 mM, Sigma) was dissolved in water (pH 10), and orthovanadate was obtained by boiling the vanadate solution (pH 10). Freshly boiled stock was diluted to final concentration (pH 7.3) prior to use. Beryllium fluoride (BeF2), as a 33% stock solution (Alfa), was dissolved in buffer solution containing 50 mM KF to produce sufficient amount of phosphate analogs BeFx (BeF<UP><SUB>3</SUB><SUP>−</SUP></UP> and BeF<UP><SUB>4</SUB><SUP>2−</SUP></UP>) (31). For electrophysiological experiments, 50 mM KF replaced 50 mM KCl in the internal solution. Second, nucleotide occlusion was induced in the absence of gamma -phosphate analogs by cooling down the membrane patch after formation of the occluded nucleotide at >30 °C (30). In these experiments we used a heating/cooling bath temperature controller (HCC-100A, Dagan Corp.) equipped with an electronically controlled high precision (±0.1 °C) and broad range Peltier thermocouple set between 4 and 32 °C.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

NBD1 Mandatory for NBD2-dependent KATP Channel Gating-- Engagement of the NBD2 ATPase cycle into discrete conformations determines KATP channel behavior (5). In this regard, gamma -phosphate analogs, orthovanadate and beryllium fluoride, are valuable tools that arrest the ATPase cycle in distinct conformations by stabilizing MgADP at the catalytic site (32-34). Here, ATPase activity in recombinant NBD2 was 77.6 ± 3.9 nmol Pi/min/mg (n = 11) and was suppressed to 17.4 ± 2.8 (n = 11) and 6.4 ± 2.2 (n = 4) nmol Pi/min/mg by 1 mM orthovanadate and beryllium fluoride, respectively (Fig. 1A). Vigorous activation of ATP-inhibited wild-type recombinant KATP channels (Kir6.2/SUR2A, Fig. 1C) produced by orthovanadate through stabilization of NBD2 in a MgADP-bound post-hydrolytic conformation (5) was disrupted not only by mutations in NBD2 but also in NBD1 (Fig. 1, B and E). Specifically, orthovanadate-induced KATP channel opening was abolished either by replacing aspartate with asparagine in the Walker B motif of the SUR2A NBD2 (D1470N), a mutation that disrupts ATP hydrolysis (3, 32), or by exchanging lysine for alanine in the Walker A motif of NBD1 (K708A), which precludes ATP binding to SUR1 (20; Fig. 1, B and E). On average, channel activity in the presence of 0.25 mM ATP and 1 mM orthovanadate was in the wild type 72 ± 18% of maximal channel opening measured in the absence of ATP (n = 4; Fig. 1B). It was reduced to 5 ± 3% in the D1470N mutant and to 3 ± 1% in the K708A mutant (n = 4; Fig. 1B). Similarly, either the D1470N or the K708A mutation reversed the inhibitory effect of beryllium fluoride (Fig. 1, B, D, and E), which traps the NBD2 ATPase in a prehydrolytic ATP-like bound state (5). Accordingly, KATP channel activity in the presence of 0.1 mM MgADP and 1 mM BeFx was in wild-type, D1470N, and K708A mutants, respectively, 8 ± 2%, 63 ± 14%, and 79 ± 10% of the maximal activity measured in the absence of nucleotide (n = 3; Fig. 1B). Thus, an intact NBD1 is required for the NBD2 ATPase dependent KATP channel gating.


View larger version (49K):
[in this window]
[in a new window]
 
Fig. 1.   Nucleotide binding domains of SUR2A required for KATP channel gating by gamma -phosphate analogs. A, gamma -phosphate analogs orthovanadate (ortho-V, 1 mM) or BeFx (1 mM) inhibit ATPase activity in recombinant NBD2. B, average channel activity of Kir6.2 co-expressed in COS-1 cells with wild-type SUR2A or with SUR2A mutated in either NBD2 (aspartate to asparagine, D1470N) or NBD1 (lysine to alanine, K708A) in the presence of gamma -phosphate analogs, orthovanadate (1 mM) plus ATP (0.25 mM) and BeFx (1 mM) plus ADP (0.1 mM), respectively. Channel activity was expressed relative to control activity measured in the absence of ATP or ADP for orthovanadate (n = 5) and BeFx (n = 4), respectively. C, vigorous opening of wild-type (wt) Kir6.2/SUR2A channels visualized in inside-out patches as a downward deflection relative to the zero current level (dotted line). Recombinant channel activity was readily inhibited by ATP (0.25 mM). ATP-induced channel inhibition was reversed by the gamma -phosphate analog orthovanadate, an effect that required 14.2 ± 0.3 min (n = 5) to reach maximal effect. During the 3-min-long break, no change in channel activity was observed. D, in contrast to orthovanadate, beryllium fluoride (BeFx = BeF2 + KF 50 mM) did not antagonize ATP-induced channel inhibition. Rather, in the presence of Mg2+ and ADP, BeFx inhibited Kir6.2/SUR2A channel opening. E, mutation (K708A) in the NBD1 Walker A motif of SUR2A prevented the effect of both orthovanadate and BeFx on KATP channels. During the 12-min-long break, no change in channel activity was observed.

ATP Stabilized at NBD1 Is Necessary for NBD2-dependent KATP Channel Gating-- MgADP at NBD2 promotes KATP channel opening (5) and concomitantly stabilizes ATP at NBD1 even in the absence of gamma -phosphate analogs (6, 19, 26). Whether such stabilization of ATP at NBD1 is required for NBD2-dependent channel gating has not been resolved thus far, as the lifetime of the MgADP-bound conformation is limited because of dissociation from NBD2 (5, 19, 26). To slow ATPase activity and promote the lifetime of MgADP at the catalytic site, we cooled membrane patches and monitored KATP channel behavior on-line. ATP inhibition of KATP channels (at >30 °C) was reversed by transient cooling (to 5 °C) of membrane patches (Fig. 2A). On average, in inside-out patches (Fig. 2B, upper panel) ATP-induced channel inhibition was markedly reduced from an initial IC50 of 25 ± 1.4 µM (n = 5-12) to 0.7 ± 0.1 mM (n = 2-5) following the cooling interval. Similarly, in open cell-attached patches (Fig. 2B, lower panel), a distinct patch condition, the sensitivity of KATP channels toward ATP was reduced from an initial IC50 of 270 ± 21 µM (n = 6-14) to 1.6 ± 0.2 mM (n = 2-7) after cooling. In contrast, cooling-induced KATP channel activation was not achieved in the presence of poorly hydrolyzable ATP analogs, AMP-PNP (n = 5; Fig. 2C) or Ap4A (n = 3; Fig. 2D). Thus, cooling does not disrupt hydrolysis-independent KATP channel gating but rather promotes MgADP stabilization at the catalytic site (30), which in turn is essential for channel opening. Although MgADP can be stabilized at NBD2 (5), excluding ATP, by application of the ADP-regenerating system hexokinase plus glucose prevented cooling-induced reduction of KATP channel sensitivity to ATP (Fig. 2E). This suggests that the presence of ATP at NBD1 is a prerequisite for MgADP to serve as a KATP channel regulator at NBD2. Indeed, in the same patch, cooling performed in the presence of ATP induced KATP channel opening, which was abolished by activation of the ADP-scavenging creatine phosphate/creatine kinase system (Fig. 2E). Therefore, cooperative stabilization of ATP and MgADP at NBDs translates into KATP channel opening at inhibitory levels of ATP.


View larger version (37K):
[in this window]
[in a new window]
 
Fig. 2.   Cooling-induced activation of KATP channels requires both MgADP and ATP. A, in a cardiomyocyte, in the open cell-attached patch configuration, native KATP channels were inhibited by 0.25 mM ATP. Transient cooling of the membrane patch (to 6 °C) reversed ATP-induced KATP channel inhibition. B, on average, the cooling interval (4-8 °C) produced a significant rightward shift in the ATP-dependent KATP channel inhibition in inside-out (upper panel) and open cell-attached (lower panel) patches. The solid lines represent Hill plots reconstructed based on parameters obtained by fitting experimental points. Cooling failed to activate KATP channels inhibited by the nonhydrolyzable ATP analogs AMP-PNP (C) or Ap4A (D). In the same patches, replacing AMP-PNP or Ap4A with ATP reversed KATP channel inhibition following cooling. E, KATP channel inhibition by 0.5 mM ATP was partially antagonized by MgADP (38 ± 7% of control activity in the absence of nucleotides, n = 3). Then, 0.5 mM ADP was clamped in the presence of the ATP-scavenging hexokinase/glucose system. Following the cooling interval, the sensitivity of KATP channel toward ATP plus MgADP (44 ± 9% of control, n = 3) as well as the sensitivity of channels to ATP alone were not significantly changed. In the same patch, cooling in the presence of MgATP antagonized channel inhibition (84 ± 6% of control activity, n = 3), an effect reversed by activation of the ADP-scavenging creatine kinase/creatine phosphate (CrP) system. All experiments were performed in open cell-attached patches. The temperature gradient is shown by a color bar on top of records.

Functional Tandem of NBD1 and NBD2 Secures KATP Channel Gating-- The cooperative binding of nucleotides at the NBDs of KATP channels (6, 19, 26) suggests a joint action of NBD1 and NBD2 on channel gating. Disruption of either NBD1 or NBD2 through mutation precluded the reduction in ATP-sensitivity observed after cooling in wild-type Kir6.2/SUR2A KATP channels (Fig. 3A). Specifically, mutations in the Walker motifs of NBD2 (K1349A and/or D1470N), which diminish the intrinsic ATPase activity (3), attenuated KATP channel activation following cooling (Fig. 3B). The time course of KATP channel activation was fitted by the Boltzmann's function, Imax·[1 + exp((T0.5 - t)/k)]-1, where Imax is the maximal channel activity expressed relative to the activity in the absence of ATP, T0.5 the time of half-activation, t the relative time of reheating, and k the slope of the time course. In wild-type Kir6.2/SUR2A channels, parameters defining the time course were as follows: Imax = 1.12 ± 0.04, T0.5 = 0.60 ± 0.03, and k = 0.24 ± 0.03 (n = 3; Fig. 3D). The K1349A/D1470N mutations significantly decreased and delayed activation of KATP channels (Imax = 0.42 ± 0.04, T0.5 = 0.92 ± 0.05, k = 0.16 ± 0.04, n = 3; Fig. 3D). Furthermore, the K708A mutation that prevents ATP binding to NBD1 (20) also abolished KATP channel activation (n = 3; Fig. 3, C and D). Thus, disrupting either NBD1 or NBD2 impedes KATP channel opening upon cooling, indicating that NBDs act as a functional unit rather than as independent determinants of channel gating.


View larger version (40K):
[in this window]
[in a new window]
 
Fig. 3.   Intact NBD1 and NBD2 of SUR2A necessary for cooling induced KATP channel opening. A, in an inside-out patch, ATP-induced inhibition of wild-type (w.t.) Kir6.2/SUR2A channels, was reversed by a cooling period. B, mutations in Walker A (1349 lysine to alanine) and B (1470 aspartate to asparagine) motifs of NBD2 in the SUR2A subunit (K1349A/D1470N) significantly reduced ATP-induced inhibition of recombinant KATP channels following cooling. C, mutation of the Walker A (708 lysine to alanine) domain of NBD1 in SUR2A (K708A) abolished the antagonism of ATP-induced KATP channel inhibition following cooling. In A-C, the temperature gradient is shown by a color bar above the records. D, average activation time course of wild-type (WT) or mutated recombinant KATP channels expressed relative to control activity measured in the absence of ATP. Time of activation was normalized to the time required for heating a particular membrane patch from 7 to 30 °C. Solid lines represent Boltzmann's curves constructed using parameters described in the text.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

In the hetero-octameric KATP channel complex (35), the sulfonylurea receptor confers fine nucleotide modulation of K+ permeation through the channel pore (7-14). In fact, the powerful metabolic sensor role of KATP channels may stem from the nonequivalent properties of NBD1 and NBD2 recognized within SUR (6, 19-22, 26). NBD1 has been demonstrated to bind nucleotides, whereas NBD2 hydrolyzes ATP (6, 19, 20, 26); yet the individual and/or collective contribution of NBDs in KATP channel gating is not fully understood. In this study, we provide functional evidence that cooperative interaction rather than the independent contribution of each NBD is critical for KATP channel regulation. These findings provide a paradigm for KATP channel gating based on the integration of both NBDs into a functional unit within the multimeric channel complex.

Specifically, although gating of cardiac KATP channels was related to discrete conformations in the ATPase cycle at NBD2 (5), it is now shown that the intactness of NBD1 is critical for this function. In agreement with cooperative binding of nucleotides to SUR, where MgADP at NBD2 promotes stabilization of ATP at NBD1 (6, 19), here ATP, but not ADP, at NBD1 was required to promote MgADP-induced opening of KATP channels in the presence of normally inhibitory concentrations of ATP.

The requirement for "cross-talk" between NBDs appears to be a common feature of several members of the ABC family. In fact, mutations of p-glycoprotein that preclude nucleotide binding or arrest ATP hydrolysis at one NBD prevent normal function at the other NBD (18, 34, 36-38). Moreover, ATP hydrolysis at both NBDs is necessary for transport of a single molecule in the p-glycoprotein transport cycle (16, 38). In the cystic fibrosis transmembrane regulator, the close proximity of NBDs (39) permits nucleotide hydrolysis at one NBD to influence nucleotide binding at the other NBD site, thereby regulating chloride conductance (40). Crystal structures of ABC-related proteins (such as the HisP of histidine permease, MalK of the trehalose/maltose transporter or the Mre11/Rad50-ATPase DNA repair complex) suggest dimerization of the two NBDs with transfer of mechanical energy from one NBD to the other within the protein architecture (41-43). In this process, ATP binding has been found critical in engaging the two NBD domains into a compact dimer essential for supporting hydrolysis-dependent protein function (42). Specifically, ATP binding has been proposed to bring the ATPase domain into a position that ultimately contributes to the "signaling-competent state" of the protein complex (43, 44). Thus, by analogy, it is conceivable that ATP binding to NBD1 of SUR is a necessary step in securing the proper structural arrangement of NBD2 required to translate conformational transitions during the ATPase cycle into KATP channel gating. This is in accord with the recent suggestion that the SUR NBD1 in its ATP-bound state directly interacts with the pore-forming Kir6.2 subunit of the KATP channel, counteracting ATP-induced channel inhibition (45).

In a cell in the basal metabolic state, ATP exceeds ADP concentration such that ATP should always be bound to NBD1, whereas hydrolysis of ATP would produce MgADP at NBD2 (Fig. 4). Although this nucleotide combination should in principle be associated with channel opening (6, 19), in a cardiac cell KATP channels are normally closed (Fig. 4). Indeed, despite continuous ATPase activity at NBD2, the product of ATP hydrolysis is rapidly removed by cellular ADP-scavenging systems, such as that catalyzed by creatine kinase, limiting the lifetime of the MgADP-bound conformation and preventing channel opening (5, 11, 46, 47) (Fig. 4). However, under metabolic stress, which suppresses creatine kinase activity (48), ADP will increase at the channel site (5). A prolonged lifetime of the MgADP-bound conformation promotes ATP stabilization at NBD1 and thereby channel opening (5, 6, 19) (Fig. 4).


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 4.   KATP channels gated through interaction between nucleotide binding domains of the SUR subunit. A "bird's eye view" of the hetero-octameric KATP channel complex composed of four pore-forming Kir6.2 and four regulatory SUR subunits, which possess two nucleotide-binding domains, NBD1 and NBD2. Under basal metabolic state (in the presence of high levels of intracellular ATP), ATP is bound to NBD1 and hydrolyzed at NBD2 by the intrinsic ATPase. Under this condition, the ADP-scavenging creatine kinase (CK) system prevents accumulation of ADP at the channel site and perpetuates the ATPase cycle impeding ATP stabilization at NBD1. Under metabolic stress, a drop in ATP regeneration increases MgADP at the channel site (5, 11) and prolongs the lifetime of the MgADP-bound conformation at NBD2 leading to entrapment of ATP at NBD1 and channel opening. Cooling and the gamma -phosphate analog orthovanadate (ortho-V) also induce channel activation by promoting cooperative nucleotide interactions at NBDs.

Although here we employed temperature to cooperatively stabilize the MgADP-bound conformation of NBD2 and ATP at NBD1 (19, 30), such a phenomenon may actually be relevant in nature as well. Indeed, KATP channel behavior has been studied in cardiac myocytes from goldfish that had been acclimated to low temperatures (7 °C) as used in this study (49). KATP channels from these animals were nearly insensitive to concentrations of ATP that were completely inhibitory in non-cold-acclimated animals (49). This observation is given a mechanistic basis by the present data, which suggest that membrane cooling promotes cooperative nucleotide stabilization at NBDs resulting in reduction of the channel's ATP sensitivity. The resulting alteration in channel activity is proposed to promote survival at low temperature by membrane potential clamping, as well as maintenance of ionic and energetic homeostasis (49). Moreover, in mammals, a cardioprotective effect of KATP channels is also present at low temperature, and this effect has been exploited in cardioplegia procedures (50). Thus, the results of the current study provide a working model of KATP channel function and point to potential avenues in addressing the biology of cold tolerance (51).

    ACKNOWLEDGEMENTS

We are grateful to Drs. K. Ueda and M. Matsuo for the critical reading of this manuscript and for giving us permission to refer to their unpublished work. We thank Drs. J. Bryan, Y. Kurachi, and S. Seino for providing KATP channel clones.

    FOOTNOTES

* This work was supported by National Institutes of Health Grants HL-64822 and HL-07111, the American Heart Association, the Miami Heart Research Institute, the American Physicians Fellowship for Medicine in Israel, the Bruce and Ruth Rappaport Program in Vascular Biology and Gene Delivery, and the Marriott Foundation.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

An Established Investigator of the American Heart Association. To whom correspondence should be addressed. Tel.: 507-284-2747; Fax: 507-84-9111; E-mail: terzic.andre@mayo.edu.

Published, JBC Papers in Press, February 1, 2002, DOI 10.1074/jbc.M109452200

2 K. Ueda and M. Matsuo, personal communication. These authors observed no ATP binding to NBD2 following mutation of the conserved lysine residue in the NBD1 Walker A motif of SUR1 isoform.

    ABBREVIATIONS

The abbreviations used are: KATP, ATP-sensitive K+; NBD, nucleotide binding domain(s); SUR, sulfonylurea receptor; ABC, ATP-binding cassette; BeFx, beryllium fluoride gamma -phosphate analog; AMP-PNP, adenosine 5'-(beta ,gamma -imino)triphosphate; Ap4A, diadenosine tetraphosphate.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1. Gulbis, J. M., Mann, S., and MacKinnon, R. (1999) Cell 97, 943-952[CrossRef][Medline] [Order article via Infotrieve]
2. Banfi, B., Maturana, A., Jaconi, S., Arnaudeau, S., Laforge, T., Sinha, B., Ligeti, E., Demaurex, N., and Krause, K. H. (2000) Science 287, 138-142[Abstract/Free Full Text]
3. Bienengraeber, M., Alekseev, A. E., Abraham, M. R., Carrasco, A. J., Moreau, C., Vivaudou, M., Dzeja, P. P., and Terzic, A. (2000) FASEB J. 14, 1943-1952[Abstract/Free Full Text]
4. Runnels, L. W., Yue, L., and Clapham, D. E. (2001) Science 291, 1043-1047[Abstract/Free Full Text]
5. Zingman, L. V., Alekseev, A. E., Bienengraeber, M., Hodgson, D., Karger, A. B., Dzeja, P. P., and Terzic, A. (2001) Neuron 31, 233-245[CrossRef][Medline] [Order article via Infotrieve]
6. Matsuo, M., Kioka, N., Amachi, T., and Ueda, K. (1999) J. Biol. Chem. 274, 37479-37482[Abstract/Free Full Text]
7. Nichols, C. G., Shyng, S., Nestorowicz, A., Glaser, B., Clement, J., Gonzalez, G., Aguilar-Bryan, L., Permutt, M., and Bryan, J. (1996) Science 272, 1785-1787[Abstract]
8. Bryan, J., and Aguilar-Bryan, L. (1999) Biochim. Biophys. Acta 1461, 285-303[Medline] [Order article via Infotrieve]
9. Seino, S. (1999) Annu. Rev. Physiol. 61, 337-362[CrossRef][Medline] [Order article via Infotrieve]
10. Abraham, M. R., Jahangir, A., Alekseev, A. E., and Terzic, A. (1999) FASEB J. 13, 1901-1910[Abstract/Free Full Text]
11. Carrasco, A. J., Dzeja, P. P., Alekseev, A. E., Pucar, D., Zingman, L. V., Abraham, M. R., Hodgson, D., Bienengraeber, M., Puceat, M., Janssen, E., Wieringa, B., and Terzic, A. (2001) Proc. Natl. Acad. Sci. U. S. A. 98, 7623-7628[Abstract/Free Full Text]
12. Aguilar-Bryan, L., Nichols, C., Wechsler, S., Clement, J., Boyd, A., Gonzalez, G., Herrerasosa, H., Nguy, K., Bryan, J., and Nelson, D. (1995) Science 268, 423-426[Abstract/Free Full Text]
13. Inagaki, N., Gonoi, T., Clement, J. P., Namba, N., Inazawa, J., Gonzalez, G., Aguilar-Bryan, L., Seino, S., and Bryan, J. (1995) Science 270, 1166-1170[Abstract/Free Full Text]
14. Inagaki, N., Gonoi, T., Clement, J. P., Wang, C. Z., Aguilar-Bryan, L., Seino, S., and Bryan, J. (1996) Neuron 16, 1011-1017[CrossRef][Medline] [Order article via Infotrieve]
15. Senior, A. E., and Gadsby, D. C. (1997) Semin. Cancer Biol. 8, 143-150[CrossRef][Medline] [Order article via Infotrieve]
16. Sauna, Z. E., and Ambudkar, S. V. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 2515-2520[Abstract/Free Full Text]
17. Ueda, K., Matsuo, M., Tanabe, K., Morita, K., Kioka, N., and Amachi, T. (1999) Biochim. Biophys. Acta 1461, 305-313[Medline] [Order article via Infotrieve]
18. Urbatsch, I. L., Beaudet, L., Carrier, I., and Gros, P. (1998) Biochemistry 37, 4592-4602[CrossRef][Medline] [Order article via Infotrieve]
19. Matsuo, M., Tanabe, K., Kioka, N., Amachi, T., and Ueda, K. (2000) J. Biol. Chem. 275, 28757-28763[Abstract/Free Full Text]
20. Ueda, K., Inagaki, N., and Seino, S. (1997) J. Biol. Chem. 272, 22983-22986[Abstract/Free Full Text]
21. Shyng, S.-L., Ferrigni, T., and Nichols, C. G. (1997) J. Gen. Physiol. 110, 643-654[Abstract/Free Full Text]
22. Gribble, F. M., Tucker, S. J., and Ashcroft, F. M. (1997) EMBO J. 16, 1145-1152[CrossRef][Medline] [Order article via Infotrieve]
23. D'hahan, N., Moreau, C., Prost, A. L., Jacquet, H., Alekseev, A. E., Terzic, A., and Vivaudou, M. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 12162-12167[Abstract/Free Full Text]
24. Babenko, A. P., Gonzalez, G., and Bryan, J. (2000) J. Biol. Chem. 275, 717-720[Abstract/Free Full Text]
25. Matsuoka, T., Matsushita, K., Katayama, Y., Fujita, A., Inageda, K., Tanemoto, M., Inanobe, A., Yamashita, S., Matsuzawa, Y., and Kurachi, Y. (2000) Circ. Res. 87, 873-880[Abstract/Free Full Text]
26. Ueda, K., Komine, J., Matsuo, M., Seino, S., and Amachi, T. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 1268-1272[Abstract/Free Full Text]
27. Matsuo, M., Trapp, S., Tanizawa, Y., Kioka, N., Amachi, T., Oka, Y., Ashcroft, F. M., and Ueda, K. (2000) J. Biol. Chem. 275, 41184-41191[Abstract/Free Full Text]
28. Gribble, F. M., Reimann, F., Ashfield, R., and Ashcroft, F. M. (2000) Mol. Pharmacol. 57, 1256-1261[Abstract/Free Full Text]
29. Alekseev, A. E., Brady, P. A., and Terzic, A. (1998) J. Gen. Physiol. 111, 381-394[Abstract/Free Full Text]
30. Szabo, K., Szakacs, G., Hegeds, T., and Sarkadi, B. (1999) J. Biol. Chem. 274, 12209-12212[Abstract/Free Full Text]
31. Goldstein, G. (1964) Anal. Chem. 36, 243-244
32. Hrycyna, C. A., Ramachandra, M., Germann, U. A., Cheng, P. W., Pastan, I., and Gottesman, M. M. (1999) Biochemistry 38, 13887-13899[CrossRef][Medline] [Order article via Infotrieve]
33. Sankaran, B., Bhagat, S., and Senior, A. E. (1997) Biochemistry 36, 6847-6853[CrossRef][Medline] [Order article via Infotrieve]
34. Takada, Y., Yamada, K., Taguchi, Y., Kino, K., Matsuo, M., Tucker, S. J., Komano, T., Amachi, T., and Ueda, K. (1998) Biochim. Biophys. Acta 1373, 131-136[Medline] [Order article via Infotrieve]
35. Clement, J. P., Kunjilwar, K., Gonzalez, G., Schwanstecher, M., Panten, U., Aguilar-Bryan, L., and Bryan, J. (1997) Neuron 18, 827-838[CrossRef][Medline] [Order article via Infotrieve]
36. Beaudet, L., Urbatsch, I. L., and Gros, P. (1998) Biochemistry 37, 9073-9082[CrossRef][Medline] [Order article via Infotrieve]
37. Senior, A. E., and Bhagat, S. (1998) Biochemistry 37, 831-836[CrossRef][Medline] [Order article via Infotrieve]
38. Sauna, Z. E., and Ambudkar, S. V. (2001) J. Biol. Chem. 276, 11653-11661[Abstract/Free Full Text]
39. Qu, Q., and Sharom, F. J. (2001) Biochemistry 40, 1413-1422[CrossRef][Medline] [Order article via Infotrieve]
40. Gadsby, D. C., and Nairn, A. C. (1999) Physiol. Rev. 70, 77-107
41. Jones, P. M., and George, A. M. (1999) FEMS Microbiol. Lett. 179, 187-202[CrossRef][Medline] [Order article via Infotrieve]
42. Diederichs, K., Diez, J., Greller, G., Muller, C., Breed, J., Schnell, C., Vonrhein, C., Boos, W., and Welte, W. (2000) EMBO J. 19, 5951-5961[CrossRef][Medline] [Order article via Infotrieve]
43. Hopfner, K. P., Karcher, A., Craig, L., Woo, T. T., Carney, J. P., and Tainer, J. A. (2001) Cell 105, 473-485[CrossRef][Medline] [Order article via Infotrieve]
44. Karpowich, N., Martsinkevich, O., Mille, L., Yuan, Y.-R., Dai, P. L., MacVey, K., Thomas, P. J., and Hunt, J. F. (2001) Structure 9, 571-586[Medline] [Order article via Infotrieve]
45. John, S. A., Weiss, J. N., and Ribalet, B. (2001) J. Gen. Physiol. 118, 391-406[Abstract/Free Full Text]
46. Weiss, J. N., and Lamp, S. T. (1987) Science 238, 67-69[Abstract/Free Full Text]
47. Dzeja, P. P., and Terzic, A. (1998) FASEB J. 12, 523-529[Abstract/Free Full Text]
48. Pucar, D., Dzeja, P. P., Bast, P., Juranic, N., Macura, S., and Terzic, A. (2001) J. Biol. Chem. 276, 44812-44819[Abstract/Free Full Text]
49. Ganim, R. B., Peckol, E. L., Larkin, J., Ruchhoeft, M. L., and Cameron, J. S. (1998) Comp. Biochem. Physiol. 119, 395-401
50. Kevelaitis, E., Peynet, J., Mouas, C., Launay, J. M., and Menasche, P. (1999) Circulation 99, 3079-3085[Abstract/Free Full Text]
51. Azzam, N. A., Hallenbeck, J. M., and Kachar, B. (2000) Nature 407, 317-318[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Endocr. Rev.Home page
L. Aguilar-Bryan and J. Bryan
Neonatal Diabetes Mellitus
Endocr. Rev., May 1, 2008; 29(3): 265 - 291.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
L.-H. Xie, S. A. John, B. Ribalet, and J. N. Weiss
Phosphatidylinositol-4,5-bisphosphate (PIP2) regulation of strong inward rectifier Kir2.1 channels: multilevel positive cooperativity
J. Physiol., April 1, 2008; 586(7): 1833 - 1848.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
A. B. Karger, S. Park, S. Reyes, M. Bienengraeber, R. B. Dyer, A. Terzic, and A. E. Alekseev
Role for SUR2A ED Domain in Allosteric Coupling within the KATP Channel Complex
J. Gen. Physiol., February 25, 2008; 131(3): 185 - 196.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. A. Burke, R. K. Mutharasan, and H. Ardehali
The Sulfonylurea Receptor, an Atypical ATP-Binding Cassette Protein, and Its Regulation of the KATP Channel
Circ. Res., February 1, 2008; 102(2): 164 - 176.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
L. V. Zingman, A. E. Alekseev, D. M. Hodgson-Zingman, and A. Terzic
ATP-sensitive potassium channels: metabolic sensing and cardioprotection
J Appl Physiol, November 1, 2007; 103(5): 1888 - 1893.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. J. Gumina, D. F. O'Cochlain, C. E. Kurtz, P. Bast, D. Pucar, P. Mishra, T. Miki, S. Seino, S. Macura, and A. Terzic
KATP channel knockout worsens myocardial calcium stress load in vivo and impairs recovery in stunned heart
Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1706 - H1713.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
S. Yamada, G. C. Kane, A. Behfar, X.-K. Liu, R. B. Dyer, R. S. Faustino, T. Miki, S. Seino, and A. Terzic
Protection conferred by myocardial ATP-sensitive K+ channels in pressure overload-induced congestive heart failure revealed in KCNJ11 Kir6.2-null mutant
J. Physiol., December 15, 2006; 577(3): 1053 - 1065.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
T. Jons, D. Wittschieber, A. Beyer, C. Meier, A. Brune, A. Thomzig, G. Ahnert-Hilger, and R. W. Veh
K+-ATP-channel-related protein complexes: potential transducers in the regulation of epithelial tight junction permeability
J. Cell Sci., August 1, 2006; 119(15): 3087 - 3097.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
P. Tammaro, P. Proks, and F. M. Ashcroft
Functional effects of naturally occurring KCNJ11 mutations causing neonatal diabetes on cloned cardiac KATP channels
J. Physiol., February 15, 2006; 571(1): 3 - 14.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. M. Prasad, A. S. Al-Dadah, G. D. Byrd, T. P. Flagg, J. Gomes, R. J. Damiano Jr, C. G. Nichols, and J. S. Lawton
Role of the Sarcolemmal Adenosine Triphosphate-Sensitive Potassium Channel in Hyperkalemic Cardioplegia-Induced Myocyte Swelling and Reduced Contractility
Ann. Thorac. Surg., January 1, 2006; 81(1): 148 - 153.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
P. Proks, C. Girard, and F. M. Ashcroft
Functional effects of KCNJ11 mutations causing neonatal diabetes: enhanced activation by MgATP
Hum. Mol. Genet., September 15, 2005; 14(18): 2717 - 2726.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. M. Hodgson, A. Behfar, L. V. Zingman, G. C. Kane, C. Perez-Terzic, A. E. Alekseev, M. Puceat, and A. Terzic
Stable benefit of embryonic stem cell therapy in myocardial infarction
Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H471 - H479.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
V. Paajanen and M. Vornanen
Regulation of action potential duration under acute heat stress by IK,ATP and IK1 in fish cardiac myocytes
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2004; 286(2): R405 - R415.
[Abstract] [Full Text] [PDF]